Tuberculosis drug resistance in bamako, mali, from 2006 to

HIGHLIGHTS

• who: B. Diarra from the activity: the national TB reference laboratory (NRL) and the biosafety level , (BSL-3) laboratory of SEREFO (HIV and TB research and training center of the University of Sciences, Techniques and Technologies of Bamako (USTTB) conduct phenotypic testing, while the private Charles Mérieux Institute laboratory has implemented the Hain MTBDRplus Line Probe Assay to detect resistance mutations to isoniazid and rifampicinThus, DST is restricted at the NRL to retreatment patients, such as those who fail, lost to follow up, or relapse after completion of the standardized , months first line therapy and no . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.